Grandeur Peak Global Advisors, LLC Castle Biosciences Inc Transaction History

Grandeur Peak Global Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $8.72 Million - $25.1 Million	-544,723 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$33.17 - $46.98 $6.84 Million - $9.69 Million	206,266 Added 60.94%	544,723 $24.4 Million
Q4 2021 Feb 15, 2022	BUY	$39.06 - $67.58 $4.19 Million - $7.24 Million	107,161 Added 46.33%	338,457 $14.5 Million
Q3 2021 Nov 16, 2021	BUY	$60.13 - $77.6 $966,770 - $1.25 Million	16,078 Added 7.47%	231,296 $15.4 Million
Q2 2021 Aug 17, 2021	BUY	$50.07 - $76.78 $8.81 Million - $13.5 Million	175,879 Added 447.09%	215,218 $15.8 Million

Q1 2021 May 18, 2021	BUY	$58.92 - $97.33 $1.8 Million - $2.97 Million	30,520 Added 346.07%	39,339 $2.69 Million
Q3 2020 Nov 17, 2020	SELL	$38.47 - $52.03 $80,056 - $108,274	-2,081 Reduced 19.09%	8,819 $454,000
Q2 2020 Aug 13, 2020	SELL	$27.28 - $43.01 $111,166 - $175,265	-4,075 Reduced 27.21%	10,900 $411,000
Q1 2020 May 18, 2020	SELL	$23.08 - $35.53 $398,129 - $612,892	-17,250 Reduced 53.53%	14,975 $446,000
Q4 2019 Feb 14, 2020	SELL	$15.74 - $35.04 $742,141 - $1.65 Million	-47,150 Reduced 59.4%	32,225 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $1.44 Million - $2.22 Million	79,375 New	79,375 $1.44 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.